Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chemours

11.25
+0.00500.04%
Volume:309.01K
Turnover:3.50M
Market Cap:1.68B
PE:62.34
High:11.48
Open:11.35
Low:11.18
Close:11.24
Loading ...

Chemours Is Maintained at Outperform by RBC Capital

Dow Jones
·
20 hours ago

RBC Cuts Price Target on Chemours to $14 From $17, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Chemours Is Maintained at Buy by UBS

Dow Jones
·
07 May

UBS Adjusts Price Target on Chemours to $17 From $18, Maintains Buy Rating

MT Newswires Live
·
07 May

Shares of Chemours Slide 13.1% After Co Cuts FY Core Profit Outlook

THOMSON REUTERS
·
07 May

Shares of Chemours Down 11.4% Premarket After Co Cuts FY Core Profit Outlook

THOMSON REUTERS
·
07 May

Stock Track | Chemours Plunges 10.83% Pre-Market on Q1 Earnings Miss, Dividend Cut, and Lowered Guidance

Stock Track
·
07 May

Chemours Q1 Adjusted Earnings Fall, Sales Rise

MT Newswires Live
·
07 May

Chemours Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Chemours Plunges 5.87% on Earnings Miss, Dividend Cut, and Lowered Guidance

Stock Track
·
07 May

Stock Track | Chemours Plunges 5.87% on Q1 Earnings Miss, Dividend Cut, and Lowered Guidance

Stock Track
·
07 May

Alembic Global Remains a Buy on Chemours Company (CC)

TIPRANKS
·
07 May

BUZZ-Chemours falls on FY core profit forecast cut, dividend slash

Reuters
·
07 May

Chemours Company Reports Q1 2025 Results: $1.4B in Net Sales, Swings to $4M Net Loss, EPS at -$0.03

Reuters
·
07 May

Chemours reports Q1 adjusted EPS 13c, consensus 20c

TIPRANKS
·
07 May

Chemours sees Q2 revenue growth low to mid-teens sequentially

TIPRANKS
·
07 May

Chemours narrows FY25 adjusted EBITDA view to $825M-$950M

TIPRANKS
·
07 May

Stock Track | Chemours Plunges 6.28% After-Hours on Mixed Q1 Results, EPS Miss

Stock Track
·
07 May

Stock Track | Chemours Stock Plunges 6.28% After-Hours on Q1 Earnings Miss Despite Revenue Beat

Stock Track
·
07 May

Chemours Q1 Adj. EPS $0.13 Misses $0.21 Estimate, Sales $1.37B Beat $1.35B Estimate

Benzinga
·
07 May